{"id":5869,"date":"2026-09-10T17:11:54","date_gmt":"2026-09-10T15:11:54","guid":{"rendered":"https:\/\/blog.lallianse.com\/?p=5869"},"modified":"2026-09-10T17:11:56","modified_gmt":"2026-09-10T15:11:56","slug":"2026-medicen-equity-story-2","status":"publish","type":"post","link":"https:\/\/blog.lallianse.com\/index.php\/2026-medicen-equity-story-2\/","title":{"rendered":"2026 Medicen : Equity Story"},"content":{"rendered":"\n<h2 class=\"wp-block-heading has-text-color has-link-color wp-elements-9795d0c609b8182da39367e37dc88b41\" style=\"color:#fecc00\"><strong>[<a href=\"https:\/\/www.linkedin.com\/search\/results\/all\/?keywords=%23equitystory&amp;origin=HASH_TAG_FROM_FEED\" target=\"_blank\" rel=\"noreferrer noopener\">#EQUITYSTORY<\/a>] Comment transformer une ambition en equity story convaincante ?<\/strong><\/h2>\n\n\n\n<p class=\"has-text-color has-link-color wp-elements-8d7f4b83f1356d5cd9d63522461655da\" style=\"color:#516d7f\">Une equity story ne consiste pas \u00e0 raconter une belle histoire&#8230; mais plut\u00f4t \u00e0 donner \u00e0 un investisseur une raison claire de comprendre\u00a0: pourquoi cette solution\u00a0? pourquoi vous\u00a0? et pourquoi maintenant\u00a0?<br><br>C\u2019est pr\u00e9cis\u00e9ment ce sujet que <a href=\"https:\/\/www.linkedin.com\/company\/medicen-paris-region\/\" target=\"_blank\" rel=\"noreferrer noopener\">Medicen Paris Region<\/a> et <a href=\"https:\/\/www.linkedin.com\/company\/parisant%C3%A9-campus\/\" target=\"_blank\" rel=\"noreferrer noopener\">PariSant\u00e9 Campus<\/a> ont choisi de confier \u00e0 <a href=\"https:\/\/www.linkedin.com\/in\/julierachline\/\" target=\"_blank\" rel=\"noreferrer noopener\">Julie Rachline<\/a>, CEO <a href=\"https:\/\/www.linkedin.com\/company\/lallianse\/\" target=\"_blank\" rel=\"noreferrer noopener\">LallianSe &#8211; Catalyseur d&rsquo;action(s)<\/a>, le 30 septembre prochain.<br><br>Ces <a href=\"https:\/\/www.linkedin.com\/search\/results\/all\/?keywords=%23conversations&amp;origin=HASH_TAG_FROM_FEED\" target=\"_blank\" rel=\"noreferrer noopener\">#conversations<\/a> s\u2019inscrivent dans un cycle de trois ateliers consacr\u00e9 \u00e0 la pr\u00e9paration d\u2019une <a href=\"https:\/\/www.linkedin.com\/search\/results\/all\/?keywords=%23lev%C3%A9edefonds&amp;origin=HASH_TAG_FROM_FEED\" target=\"_blank\" rel=\"noreferrer noopener\">#lev\u00e9edefonds<\/a>, avec \u00e9galement <a href=\"https:\/\/www.linkedin.com\/in\/claire-verschelde-2706445\/\" target=\"_blank\" rel=\"noreferrer noopener\">Claire Verschelde<\/a> (@<a href=\"https:\/\/www.linkedin.com\/company\/icosa-group\/\" target=\"_blank\" rel=\"noreferrer noopener\">ICOSA | European Intellectual Property Firm<\/a>) &amp; matthieu collin (Inserm Transfert) et enfin <a href=\"https:\/\/www.linkedin.com\/in\/nabil-gharios-562193\/\" target=\"_blank\" rel=\"noreferrer noopener\">Nabil Gharios<\/a> \u2013 <a href=\"https:\/\/www.linkedin.com\/company\/dna-finance\/\" target=\"_blank\" rel=\"noreferrer noopener\">DNA Finance<\/a>.<br><br>Un format qui r\u00e9unit, au bon moment, les expertises dont les fondateurs <a href=\"https:\/\/www.linkedin.com\/search\/results\/all\/?keywords=%23healthtech&amp;origin=HASH_TAG_FROM_FEED\" target=\"_blank\" rel=\"noreferrer noopener\">#HealthTech<\/a> ont besoin pour pr\u00e9parer leur prochaine \u00e9tape.<br><br>\ud83d\udcc5 8 septembre, 30 septembre et 15 octobre 2026<br>\ud83d\udd58 De 9h \u00e0 10h30<br>\ud83d\udccd PariSant\u00e9 Campus<br>\ud83d\udd17 Infos et inscriptions <a href=\"https:\/\/lnkd.in\/egvECXuN\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/lnkd.in\/egvECXuN<\/a><br>\ud83c\udf9f\ufe0f R\u00e9serv\u00e9 aux adh\u00e9rents Medicen et aux membres de PariSant\u00e9 Campus &#8211; les places sont limit\u00e9es.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity is-style-wide\"\/>\n\n\n\n<h4 class=\"wp-block-heading has-text-color has-link-color wp-elements-00c1135be747b3bb5a9c5b5979e3ea18\" style=\"color:#fecc00\"><strong>Retour sur le 1er atelier : <\/strong><\/h4>\n\n\n\n<p class=\"has-text-color has-link-color wp-elements-6c37a5b4a52ea8adc4cf16acbc475a47\" style=\"color:#516d7f\">Avec <a href=\"https:\/\/www.linkedin.com\/in\/claire-verschelde-2706445\/\">Claire Verschelde<\/a> (<a href=\"https:\/\/www.linkedin.com\/company\/icosa-group\/\">ICOSA | European Intellectual Property Firm<\/a>) et <a href=\"https:\/\/www.linkedin.com\/in\/matthieu-collin-0136462a\/\">matthieu collin<\/a> (<a href=\"https:\/\/www.linkedin.com\/company\/inserm-transfert\/\">Inserm Transfert<\/a>)<\/p>\n\n\n\n<iframe loading=\"lazy\" src=\"https:\/\/www.linkedin.com\/embed\/feed\/update\/urn:li:share:7485326717482622976\" height=\"1258\" width=\"504\" frameborder=\"0\" allowfullscreen=\"\" title=\"Post int\u00e9gr\u00e9\"><\/iframe>\n","protected":false},"excerpt":{"rendered":"<p>[#EQUITYSTORY] Comment transformer une ambition en equity story convaincante ? Une equity story ne consiste pas \u00e0 raconter une belle histoire&#8230; mais plut\u00f4t \u00e0 donner \u00e0 un investisseur une raison claire de comprendre\u00a0: pourquoi cette solution\u00a0? pourquoi vous\u00a0? et pourquoi maintenant\u00a0? C\u2019est pr\u00e9cis\u00e9ment ce sujet que Medicen Paris Region et PariSant\u00e9 Campus ont choisi de &hellip; <a href=\"https:\/\/blog.lallianse.com\/index.php\/2026-medicen-equity-story-2\/\" class=\"more-link\">Continuer la lecture<span class=\"screen-reader-text\"> de &laquo;&nbsp;2026 Medicen : Equity Story&nbsp;&raquo;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":5879,"comment_status":"closed","ping_status":"closed","sticky":true,"template":"","format":"standard","meta":{"advanced_seo_description":"EQUITYSTORY pr\u00e9cis\u00e9ment ce sujet que Medicen Paris Region et PariSant\u00e9 Campus ont choisi de confier \u00e0 Julie Rachline, CEO LallianSe - Catalyseur d'action(s)","jetpack_seo_html_title":"EQUITYSTORY  Julie Rachline, CEO LallianSe - Catalyseur d'action(s)","jetpack_seo_noindex":false,"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"footnotes":"","_jetpack_memberships_contains_paid_content":false},"categories":[260,264],"tags":[],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/blog.lallianse.com\/wp-content\/uploads\/2026\/09\/Petit-dej-levee-de-fonds_format-16_9.png","jetpack-related-posts":[],"_links":{"self":[{"href":"https:\/\/blog.lallianse.com\/index.php\/wp-json\/wp\/v2\/posts\/5869"}],"collection":[{"href":"https:\/\/blog.lallianse.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blog.lallianse.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blog.lallianse.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/blog.lallianse.com\/index.php\/wp-json\/wp\/v2\/comments?post=5869"}],"version-history":[{"count":8,"href":"https:\/\/blog.lallianse.com\/index.php\/wp-json\/wp\/v2\/posts\/5869\/revisions"}],"predecessor-version":[{"id":5886,"href":"https:\/\/blog.lallianse.com\/index.php\/wp-json\/wp\/v2\/posts\/5869\/revisions\/5886"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/blog.lallianse.com\/index.php\/wp-json\/wp\/v2\/media\/5879"}],"wp:attachment":[{"href":"https:\/\/blog.lallianse.com\/index.php\/wp-json\/wp\/v2\/media?parent=5869"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blog.lallianse.com\/index.php\/wp-json\/wp\/v2\/categories?post=5869"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blog.lallianse.com\/index.php\/wp-json\/wp\/v2\/tags?post=5869"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}